-
Je něco špatně v tomto záznamu ?
Design, synthesis and biological evaluation of substituted 3-amino-N-(thiazol-2-yl)pyrazine-2-carboxamides as inhibitors of mycobacterial methionine aminopeptidase 1
M. Juhás, VSK. Pallabothula, K. Grabrijan, M. Šimovičová, O. Janďourek, K. Konečná, P. Bárta, P. Paterová, S. Gobec, I. Sosič, J. Zitko
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Odkazy
PubMed
34826708
DOI
10.1016/j.bioorg.2021.105489
Knihovny.cz E-zdroje
- MeSH
- aminopeptidasy antagonisté a inhibitory metabolismus MeSH
- antituberkulotika MeSH
- inhibitory enzymů chemická syntéza chemie farmakologie MeSH
- mikrobiální testy citlivosti MeSH
- molekulární struktura MeSH
- Mycobacterium tuberculosis účinky léků enzymologie MeSH
- pyraziny chemická syntéza chemie farmakologie MeSH
- racionální návrh léčiv * MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) is the number one cause of deaths due to a single infectious agent worldwide. The treatment of TB is lengthy and often complicated by the increasing drug resistance. New compounds with new mechanisms of action are therefore needed. We present the design, synthesis, and biological evaluation of pyrazine-based inhibitors of a prominent antimycobacterial drug target - mycobacterial methionine aminopeptidase 1 (MtMetAP1). The inhibitory activities of the presented compounds were evaluated against the MtMetAP1a isoform, and all derivatives were tested against a broad spectrum of myco(bacteria) and fungi. The cytotoxicity of the compounds was also investigated using Hep G2 cell lines. Overall, high inhibition of the isolated enzyme was observed for 3-substituted N-(thiazol-2-yl)pyrazine-2-carboxamides, particularly when the substituent was represented by 2-substituted benzamide. The extent of inhibition was strongly dependent on the used metal cofactor. The highest inhibition was seen in the presence of Ni2+. Several compounds also showed mediocre in vitro potency against Mtb (both Mtb H37Ra and H37Rv). Despite the structural similarities of bacterial and fungal MetAP1 to mycobacterial MtMetAP1, title compounds did not exert antibacterial nor antifungal activity. The reasons behind the higher activity of 2-substituted benzamido derivatives, as well as the correlation of enzyme inhibition with the in vitro growth inhibition activity is discussed.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011429
- 003
- CZ-PrNML
- 005
- 20220506125817.0
- 007
- ta
- 008
- 220425s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bioorg.2021.105489 $2 doi
- 035 __
- $a (PubMed)34826708
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Juhás, Martin $u Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: juhasm@faf.cuni.cz
- 245 10
- $a Design, synthesis and biological evaluation of substituted 3-amino-N-(thiazol-2-yl)pyrazine-2-carboxamides as inhibitors of mycobacterial methionine aminopeptidase 1 / $c M. Juhás, VSK. Pallabothula, K. Grabrijan, M. Šimovičová, O. Janďourek, K. Konečná, P. Bárta, P. Paterová, S. Gobec, I. Sosič, J. Zitko
- 520 9_
- $a Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) is the number one cause of deaths due to a single infectious agent worldwide. The treatment of TB is lengthy and often complicated by the increasing drug resistance. New compounds with new mechanisms of action are therefore needed. We present the design, synthesis, and biological evaluation of pyrazine-based inhibitors of a prominent antimycobacterial drug target - mycobacterial methionine aminopeptidase 1 (MtMetAP1). The inhibitory activities of the presented compounds were evaluated against the MtMetAP1a isoform, and all derivatives were tested against a broad spectrum of myco(bacteria) and fungi. The cytotoxicity of the compounds was also investigated using Hep G2 cell lines. Overall, high inhibition of the isolated enzyme was observed for 3-substituted N-(thiazol-2-yl)pyrazine-2-carboxamides, particularly when the substituent was represented by 2-substituted benzamide. The extent of inhibition was strongly dependent on the used metal cofactor. The highest inhibition was seen in the presence of Ni2+. Several compounds also showed mediocre in vitro potency against Mtb (both Mtb H37Ra and H37Rv). Despite the structural similarities of bacterial and fungal MetAP1 to mycobacterial MtMetAP1, title compounds did not exert antibacterial nor antifungal activity. The reasons behind the higher activity of 2-substituted benzamido derivatives, as well as the correlation of enzyme inhibition with the in vitro growth inhibition activity is discussed.
- 650 _2
- $a aminopeptidasy $x antagonisté a inhibitory $x metabolismus $7 D000626
- 650 _2
- $a antituberkulotika $7 D000995
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 12
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a inhibitory enzymů $x chemická syntéza $x chemie $x farmakologie $7 D004791
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a Mycobacterium tuberculosis $x účinky léků $x enzymologie $7 D009169
- 650 _2
- $a pyraziny $x chemická syntéza $x chemie $x farmakologie $7 D011719
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pallabothula, Vinod S K $u Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: pallabov@faf.cuni.cz
- 700 1_
- $a Grabrijan, Katarina $u University of Ljubljana, Faculty of Pharmacy, Aškerčeva cesta 7, SI-1000 Ljubljana, Slovenia. Electronic address: katarina.grabrijan@ffa.uni-lj.si
- 700 1_
- $a Šimovičová, Martina $u Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: simovicm@faf.cuni.cz
- 700 1_
- $a Janďourek, Ondřej $u Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: jando6aa@faf.cuni.cz
- 700 1_
- $a Konečná, Klára $u Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: konecna@faf.cuni.cz
- 700 1_
- $a Bárta, Pavel $u Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: pavel.barta@faf.cuni.cz
- 700 1_
- $a Paterová, Pavla $u University Hospital Hradec Králové, Department of Clinical Microbiology, Sokolská 581, 500 05 Hradec Králové, Czech Republic. Electronic address: pavla.paterova@fnhk.cz
- 700 1_
- $a Gobec, Stanislav $u University of Ljubljana, Faculty of Pharmacy, Aškerčeva cesta 7, SI-1000 Ljubljana, Slovenia. Electronic address: stanislav.gobec@ffa.uni-lj.si
- 700 1_
- $a Sosič, Izidor $u University of Ljubljana, Faculty of Pharmacy, Aškerčeva cesta 7, SI-1000 Ljubljana, Slovenia. Electronic address: izidor.sosic@ffa.uni-lj.si
- 700 1_
- $a Zitko, Jan $u Charles University, Faculty of Pharmacy in Hradec Králové, Akademika Heyrovského 1203, 500 05 Hradec Králové, Czech Republic. Electronic address: jan.zitko@faf.cuni.cz
- 773 0_
- $w MED00000771 $t Bioorganic chemistry $x 1090-2120 $g Roč. 118, č. - (2022), s. 105489
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34826708 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506125809 $b ABA008
- 999 __
- $a ok $b bmc $g 1789160 $s 1162627
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 118 $c - $d 105489 $e 20211114 $i 1090-2120 $m Bioorganic chemistry $n Bioorg Chem $x MED00000771
- LZP __
- $a Pubmed-20220425